These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3127307)

  • 1. Control of human plasminogen activation.
    Castellino FJ; Urano T; de Serrano V; Morris JP; Chibber BA
    Haemostasis; 1988; 18 Suppl 1():15-23. PubMed ID: 3127307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
    Lin LF; Houng A; Reed GL
    Biochemistry; 2000 Apr; 39(16):4740-5. PubMed ID: 10769130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase.
    Urano T; Chibber BA; Castellino FJ
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4031-4. PubMed ID: 3473492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator.
    Urano T; Sator de Serrano V; Gaffney PJ; Castellino FJ
    Biochemistry; 1988 Aug; 27(17):6522-8. PubMed ID: 3146348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activator.
    Sazonova IY; Robinson BR; Gladysheva IP; Castellino FJ; Reed GL
    J Biol Chem; 2004 Jun; 279(24):24994-5001. PubMed ID: 15069059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation.
    Menhart N; Hoover GJ; McCance SG; Castellino FJ
    Biochemistry; 1995 Feb; 34(5):1482-8. PubMed ID: 7849007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody to the epsilon-aminocaproic acid binding site on the kringle 4 region of human plasminogen that accelerates the activation of Glu1-plasminogen by urokinase.
    Cummings HS; Castellino FJ
    Arch Biochem Biophys; 1985 Feb; 236(2):612-8. PubMed ID: 2982318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride.
    Guinn L; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):315-20. PubMed ID: 14743974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M; Zenker M; Gaffney PJ
    Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of lysine binding sites in activation of plasminogen by streptokinase].
    Sokolovskaia LI; Makogonenko EM; Grinenko TV; Cederholm-Williams SA
    Ukr Biokhim Zh (1999); 2003; 75(2):25-32. PubMed ID: 14577167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of nonproteolytic active site formation in plasminogen.
    Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
    Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
    Lee PP; Wohl RC; Boreisha IG; Robbins KC
    Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen.
    Takada Y; Makino Y; Takada A
    Thromb Res; 1985 Aug; 39(3):289-96. PubMed ID: 4049320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
    Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
    Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the lysine binding sites of human plasminogen in the fibrinogen stimulated rate of active site formation in the streptokinase-plasminogen equimolar complex.
    Smith JH; Morris JP; Chibber BA; Castellino FJ
    Thromb Res; 1984 Jun; 34(6):499-506. PubMed ID: 6429889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ; Fredenburgh JC; Weitz JI
    J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma.
    Gaffney PJ; Urano T; de Serrano VS; Mahmoud-Alexandroni M; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3595-8. PubMed ID: 3130631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.
    Takada Y; Takada A
    Haemostasis; 1987; 17(1-2):1-7. PubMed ID: 3596355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.